Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6757747 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL996547 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL996546 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL95650 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL2735605 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10405962 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL14658031 | 0.97 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL16690502 | 0.92 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10844984 | 0.89 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10535023 | 0.89 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3296306-B1 | BASE-PROTECTED OLIGONUCLEOTIDE | AJINOMOTO KK (JP) | 2022-11-09 | — | — | EP | disclosed |
| EP-2816053-B1 | BASE-PROTECTED OLIGONUCLEOTIDE | AJINOMOTO KK (JP) | 2021-03-24 | — | — | EP | disclosed |
| CN-106977567-B | Oligonucleotide with protected base moiety | 味之素株式会社 | 2021-02-02 | — | — | CN | disclosed |
| CN-107011132-B | Aromatic compound containing branched chain | 味之素株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-107011131-B | Aromatic compound containing branched chain | 味之素株式会社 | 2020-11-10 | — | — | CN | disclosed |
| EP-2612845-B1 | AROMATIC COMPOUND CONTAINING SPECIFIC BRANCH | AJINOMOTO KK (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-2612845-B1 | AROMATIC COMPOUND CONTAINING SPECIFIC BRANCH | AJINOMOTO KK (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-10711033-B2 | Branched chain-containing aromatic compound | AJINOMOTO CO., INC. (JP) | 2020-07-14 | — | — | US | disclosed |
| CN-106220482-B | Aromatic compound containing branched chain | 味之素株式会社 | 2020-01-07 | — | — | CN | disclosed |
| US-10290809-B2 | Macromolecular compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-14 | — | — | US | disclosed |
| US-6500892-B1 | SATURATED ISOPRENE OLIGOMER BONDED TO A POLAR GROUP, QUATERNARY AMMONIUM | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2002-12-31 | — | — | US | disclosed |
| EP-1242359-A2 | INTERCALATED CLAY MATERIAL USEFUL FOR MAKING ALPHA-OLEFIN POLYMER NANOCOMPOSITES AND INTERCALANT COMPOUND USED THEREIN | Basell Poliolefine Italia S.p.A. (IT) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001096237-A2 | INTERCALATED CLAY MATERIAL USEFUL FOR MAKING ALPHA-OLEFIN POLYMER NANOCOMPOSITES AND INTERCALANT COMPOUND USED THEREIN | BASELL TECHNOLOGY COMPANY B.V. (US) | 2001-12-20 | — | — | WO | disclosed |
| US-4904823-A | Hydroquinone derivatives and a process for their preparation | HOFFMANN-LA ROCHE INC. (US) | 1990-02-27 | — | — | US | disclosed |
| US-4824972-A | Hydroquinone derivatives | HOFFMANN-LAROCHE INC. (US) | 1989-04-25 | — | — | US | disclosed |
| US-4743696-A | Hydroquinone derivatives and a process for their preparation | HOFFMANN-LA ROCHE INC. (US) | 1988-05-10 | — | — | US | disclosed |
| US-4709055-A | (Alkoxy-methyl)-phenyl-methyl-epoxybutanes | HOFFMANN-LA ROCHE INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4689427-A | Hydroquinone derivatives useful in the production of vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1987-08-25 | — | — | US | disclosed |
| US-4675421-A | Hydroquinone derivatives and a process for their preparation | HOFFMANN-LA ROCHE INC. (US) | 1987-06-23 | — | — | US | disclosed |
| US-4582919-A | Process for the manufacture of optically active compounds | HOFFMANN-LA ROCHE INC. (US) | 1986-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711033-B2 | Branched chain-containing aromatic compound | VIP, IAPP, BCAT1 | LMNA 2252/4885BLM 2109/4885PTPN1 3937/4885 |
| US-10290809-B2 | Macromolecular compound | EXOSC4, TRPC6, MRPS22 | LMNA 3835/4885BLM 567/4885PTPN1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.